Neste vídeo, Dra. Ariane S. Macedo, diretora da Galen Academy e professora da Faculdade de Ciências Médicas da Santa Casa de Misericórdia de São Paulo, comenta sobre dois estudos apresentados na sessão de Late-Breaking Trials do American College of Cardiology Annual Scientific Session (ACC.23/WCC). São abordados os estudos clínicos STOP-CA e BETTER CARE-HF.
Destaques do ACC.23/WCC: estudos clínicos STOP-CA e BETTER CARE-HF
Escrito por: MDHealth em 15 de março de 2023
1 min de leitura
Referências
Tomas G. Neilan et al., 402-10 – Statins To Prevent The Cardiotoxicity From Anthracyclines: The STOP-CA Trial. Presented at American College of Cardiology Annual Scientific Session (ACC.23/WCC).
Amrita Mukhopadhyay, et al., 406-08 – Building Electronic Tools To Enhance And Reinforce CArdiovascular REcommendations For Heart Failure (BETTER CARE-HF): A Pragmatic, Cluster-randomized Trial Comparing Two Ambulatory Clinical Decision Support Tools. Presented at American College of Cardiology Annual Scientific Session (ACC.23/WCC).
